{"organizations": [], "uuid": "9e562358175dbb01fd1a13435f485d371d4a8828", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/03/12/the-associated-press-amphastar-beats-street-4q-forecasts.html", "country": "US", "domain_rank": 767, "title": "Amphastar beats Street 4Q forecasts", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-12T23:29:00.000+02:00", "replies_count": 0, "uuid": "9e562358175dbb01fd1a13435f485d371d4a8828"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/03/12/the-associated-press-amphastar-beats-street-4q-forecasts.html", "ord_in_thread": 0, "title": "Amphastar beats Street 4Q forecasts", "locations": [], "entities": {"persons": [], "locations": [{"name": "rancho cucamonga", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}], "organizations": [{"name": "amph", "sentiment": "negative"}, {"name": "amphastar pharmaceuticals inc.", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}, {"name": "rancho cucamonga", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "RANCHO CUCAMONGA, Calif. (AP) _ Amphastar Pharmaceuticals Inc. (AMPH) on Monday reported fourth-quarter net income of $1.5 million, after reporting a loss in the same period a year earlier.\nOn a per-share basis, the Rancho Cucamonga, California-based company said it had profit of 3 cents. Earnings, adjusted for non-recurring costs, came to 10 cents per share.\nThe results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 4 cents per share.\nThe specialty pharmaceutical company posted revenue of $60.4 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $60.1 million.\nFor the year, the company reported profit of $4.5 million, or 9 cents per share. Revenue was reported as $240.2 million.\nAmphastar shares have increased nearly 2 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $19.58, a rise of 34 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on AMPH at https://www.zacks.com/ap/AMPH", "external_links": [], "published": "2018-03-12T23:29:00.000+02:00", "crawled": "2018-03-13T03:38:22.004+02:00", "highlightTitle": ""}